Regulatory Considerations for Approval of Generic Inhalation Drug Products in the US, EU, Brazil, China, and India
Crossref DOI link: https://doi.org/10.1208/s12248-015-9787-8
Published Online: 2015-05-23
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Sau L.
Saluja, Bhawana
GarcĂa-Arieta, Alfredo
Santos, Gustavo Mendes Lima
Li, Ying
Lu, Sarah
Hou, Shuguang
Rebello, Juliet
Vaidya, Abhijit
Gogtay, Jaideep
Purandare, Shrinivas
Lyapustina, Svetlana
Text and Data Mining valid from 2015-05-23